Identification and Validation of the GSK3 Targets in the Heart

Project Details

StatusFinished
Effective start/end date1/09/1231/08/15

Funding

  • British Heart Foundation (PG/12/3/29344): £211,449.00

Research Output

A partnership with the proteasome: the destructive nature of GSK3

Robertson, H., Hayes, J. D. & Sutherland, C., Jan 2018, In : Biochemical Pharmacology. 147, p. 77-92 16 p.

Research output: Contribution to journalArticle

Open Access
File
  • 14 Citations (Scopus)
    166 Downloads (Pure)

    Rab-GTPase binding effector protein 2 (RABEP2) is a primed substrate for Glycogen Synthase kinase-3 (GSK3)

    Logie, L., Van Aalten, L., Knebel, A., Force, T., Hastie, C. J., MacLauchlan, H., Campbell, D. G., Gourlay, R., Prescott, A., Davidson, J., Fuller, W. & Sutherland, C., 15 Dec 2017, In : Scientific Reports. 7, p. 1-14 14 p., 17682.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 2 Citations (Scopus)
    153 Downloads (Pure)